The price of CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares last traded on Wall Street fell -12.02% to $0.22.
CERO stock price is now 84.46% away from the 50-day moving average and -77.68% away from the 200-day moving average. The market capitalization of the company currently stands at $28.84M.
In other news, SLOAN STUART M, 10% Owner sold 532,486 shares of the company’s stock on Sep 25 ’24. The stock was sold for $55,538 at an average price of $0.10. Upon completion of the transaction, the 10% Owner now directly owns 21,067,956 shares in the company, valued at $4.63 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 10 ’24, 10% Owner YK Bioventures Opportunities G sold 3,250,000 shares of the business’s stock. A total of $325,000 was realized by selling the stock at an average price of $0.10. This leaves the insider owning 22,620,783 shares of the company worth $4.98 million. A total of 34.92% of the company’s stock is owned by insiders.
During the past 12 months, CERo Therapeutics Holdings Inc has had a low of $0.06 and a high of $12.80. The fifty day moving average price for CERO is $0.11826 and a two-hundred day moving average price translates $0.977015 for the stock.
The latest earnings results from CERo Therapeutics Holdings Inc (NASDAQ: CERO) was released for 2024-06-30. The company reported revenue of $4.4 million for the quarter, compared to $1.54 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 186.59 percent.
